Skip to main content
Top
Published in: Intensive Care Medicine 3/2006

01-03-2006 | Original

Mean glucose level is not an independent risk factor for mortality in mixed ICU patients

Authors: Jack J. M. Ligtenberg, Sofie Meijering, Ymkje Stienstra, Iwan C. C. van der Horst, Mathijs Vogelzang, Maarten W. N. Nijsten, Jaap E. Tulleken, Jan G. Zijlstra

Published in: Intensive Care Medicine | Issue 3/2006

Login to get access

Abstract

Objective

To find out if there is an association between hyperglycaemia and mortality in mixed ICU patients.

Design and setting

Retrospective cohort study over a 2-year period at the medical ICU of a university hospital.

Measurements

Admission glucose, maximum and mean glucose, length of stay, mortality, insulin therapy and Apache-II score.

Results

In 1085 consecutive patients, ICU- and hospital mortality were 20 and 25%, respectively. The total number of blood glucose measurements was 10.012. Admission glucose was 7.9 ± 4.5 mmol/l (mean ± SD), mean glucose 7.5 ± 2.9 and maximum glucose 10.0 ± 5.4 mmol/l. Median ICU length of stay (LOS) was 3.0 days (range 2.0–6.0 days, IQR), and hospital LOS was 16 days (range 7–32 days). In 28% of patients insulin treatment was started. Median Apache-II score was 13. 68% of patients were mechanically ventilated. Univariate analysis showed an association with ICU mortality for mean glucose (non-survivors 8.6 ± 4.3 vs 7.2 ± 2.4 survivors), maximum glucose (11.7 ± 5.9 vs 9.6 ± 5.2, non-survivors vs survivors, respectively), use of insulin (mortality 29 vs 17% in patients not using insulin) and age (61 vs 55.7 years). Gender and a history of diabetes mellitus were not associated with mortality. In a multivariate model, the Apache-II score was the only variable associated with mortality independent of other variables, including mean blood glucose.

Conclusion

In this retrospective study mean glucose level was not an independent risk factor for mortality in mixed ICU patients.
Literature
1.
go back to reference van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef
2.
go back to reference van der Horst IC, Gans RO, Nijsten MW, Ligtenberg JJ (2003) Beneficial effect of glucose-insulin-potassium infusion in noncritically ill patients has to be proven. J Intern Med 254:513PubMedCrossRef van der Horst IC, Gans RO, Nijsten MW, Ligtenberg JJ (2003) Beneficial effect of glucose-insulin-potassium infusion in noncritically ill patients has to be proven. J Intern Med 254:513PubMedCrossRef
3.
go back to reference van der Horst IC, Gans RO, Zijlstra F, Ligtenberg JJ (2004) Exogenous insulin and hypoglycemia as prognostic factors in critically ill patients. J Am Med Assoc 291:558–559CrossRef van der Horst IC, Gans RO, Zijlstra F, Ligtenberg JJ (2004) Exogenous insulin and hypoglycemia as prognostic factors in critically ill patients. J Am Med Assoc 291:558–559CrossRef
4.
go back to reference van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366PubMedCrossRef van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366PubMedCrossRef
5.
go back to reference Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471–1478PubMed Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471–1478PubMed
6.
go back to reference Christiansen C, Toft P, Jorgensen HS, Andersen SK, Tonnesen E (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688PubMedCrossRef Christiansen C, Toft P, Jorgensen HS, Andersen SK, Tonnesen E (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688PubMedCrossRef
7.
go back to reference Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN (2005) Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 33:2772–2777PubMedCrossRef Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN (2005) Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 33:2772–2777PubMedCrossRef
8.
go back to reference Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992–1000PubMedCrossRef Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992–1000PubMedCrossRef
Metadata
Title
Mean glucose level is not an independent risk factor for mortality in mixed ICU patients
Authors
Jack J. M. Ligtenberg
Sofie Meijering
Ymkje Stienstra
Iwan C. C. van der Horst
Mathijs Vogelzang
Maarten W. N. Nijsten
Jaap E. Tulleken
Jan G. Zijlstra
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 3/2006
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-005-0052-y

Other articles of this Issue 3/2006

Intensive Care Medicine 3/2006 Go to the issue